Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
Authors
Keywords
PI3K/AKT/mTOR, Cancer, miRNA, Metastasis, Angiogenesis, Drug resistance
Journal
LIFE SCIENCES
Volume 285, Issue -, Pages 119984
Publisher
Elsevier BV
Online
2021-09-28
DOI
10.1016/j.lfs.2021.119984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis
- (2021) Shuhong Yin et al. International Journal of General Medicine
- MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling
- (2021) Qingfeng Ni et al. Aging-US
- PI3 kinase signaling pathway in hematopoietic cancers: A glance in miRNA's role
- (2021) Elham Roshandel et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer
- (2021) Jie Ni et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
- (2021) Chao Dong et al. Frontiers in Pharmacology
- MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway
- (2021) Yuguo Zhao et al. Journal of Oncology
- microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway
- (2021) Xiao-Li Yang et al. CELLULAR SIGNALLING
- 17β-Estradiol Exacerbated Experimental Occlusal Interference-Induced Chronic Masseter Hyperalgesia by Increasing the Neuronal Excitability and TRPV1 Function of Trigeminal Ganglion in Ovariectomized Rats
- (2021) Yun Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor
- (2021) Tianyu He et al. Frontiers in Physiology
- Regulatory Mechanism of MicroRNA Expression in Cancer
- (2020) Zainab Ali Syeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
- (2020) Mohammad Mirza-Aghazadeh-Attari et al. LIFE SCIENCES
- Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway
- (2020) Ana Sanches-Silva et al. PHARMACOLOGICAL RESEARCH
- miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway
- (2020) Zhang Xuefang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
- (2020) Wu Yang et al. OncoTargets and Therapy
- The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway
- (2020) Yunyan Wan et al. OncoTargets and Therapy
- Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
- (2020) Aaron C. Tan Thoracic Cancer
- Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway
- (2020) Wenjun Li et al. Frontiers in Pharmacology
- Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer
- (2020) Farzad Rahmani et al. GENE
- The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
- (2020) Ina Nepstad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands
- (2020) Xiaohui Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
- (2020) Ningni Jiang et al. MOLECULAR BIOLOGY REPORTS
- MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression
- (2020) Yong-Mei Zhou et al. Cancer Biomarkers
- Challenges and Opportunities in Cancer Drug Resistance
- (2020) Richard A. Ward et al. CHEMICAL REVIEWS
- MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma
- (2020) Chengyi Jiang et al. Genes & Genomics
- The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
- (2020) Boris Y. Shorning et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway
- (2020) Wenbiao Liao et al. LIFE SCIENCES
- MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells
- (2020) Bei Zhu et al. OncoTargets and Therapy
- MicroRNA‑654‑3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells
- (2020) Yi‑Chao Niu et al. Experimental and Therapeutic Medicine
- PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
- (2020) Nicola Fusco et al. Genes
- Structural Insights into TOR Signaling
- (2020) Lucas Tafur et al. Genes
- microRNA-582 Potentiates Liver and Lung Metastasis of Gastric Carcinoma Cells Through the FOXO3-Mediated PI3K/Akt/Snail Pathway
- (2020) Tianyu Xie et al. Cancer Management and Research
- Development of MicroRNAs as Potential Therapeutics against Cancer
- (2020) Noraini Abd-Aziz et al. Journal of Oncology
- LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway
- (2020) Zhe Wu et al. CELL CYCLE
- MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2
- (2020) Yunyan Zhou et al. OncoTargets and Therapy
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- miRNA-425-5p enhances lung cancer growth via the PTEN/PI3K/AKT signaling axis
- (2020) Jin-shan Zhou et al. BMC Pulmonary Medicine
- MicroRNA-1179 suppresses the proliferation and enhances vincristine sensitivity of oral cancer cells via induction of apoptosis and modulation of MEK/ERK and PI3K/AKT signalling pathways
- (2020) Yanmei Gao et al. AMB Express
- AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma
- (2020) Timon A. Bloedjes et al. Blood Advances
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- The inhibition of hypoxia-induced angiogenesis and metastasis by cinnamaldehyde is mediated by decreasing HIF-1α protein synthesis via PI3K/Akt pathway
- (2019) Kartick Patra et al. BIOFACTORS
- The relation between PI3K/AKT signalling pathway and cancer
- (2019) Saeed Noorolyai et al. GENE
- L ncRNA‐XIST/microRNA‐126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma
- (2019) Zhihua Cheng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
- (2019) Maryam Abolghasemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
- (2019) Farzad Rahmani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA‐425‐5p promotes breast cancer cell growth by inducing PI3K/AKT signaling
- (2019) Li‐Feng Zhang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer
- (2019) Meran Keshawa Ediriweera et al. PHARMACOLOGY & THERAPEUTICS
- Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
- (2019) Raluca Ioana Teleanu et al. Journal of Clinical Medicine
- Downregulation of HIF-1α inhibits the proliferation, migration and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression
- (2018) Jingjing Zhang et al. BIOSCIENCE REPORTS
- PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy
- (2018) Nahal Haddadi et al. Molecular Cancer
- Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway
- (2018) Afsaneh Sadremomtaz et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- PI3k/AKT signaling pathway: Erythropoiesis and beyond
- (2018) Mahjoobeh Jafari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
- (2018) Zahra Nozhat et al. DARU-Journal of Pharmaceutical Sciences
- Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
- (2018) Aynaz Mihanfar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis
- (2017) Chaojing Lu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway
- (2017) Bai-Sheng Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms’ Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway
- (2017) Ge-Liang Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
- (2017) Qiuran Xu et al. Molecular Cancer
- MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
- (2017) Nana Li et al. Cell Death & Disease
- miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN
- (2017) Xiaomin Yu et al. Oncology Letters
- Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
- (2017) Bin Li et al. Oncotarget
- MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A
- (2017) Chunmei Li et al. Journal of Cancer
- Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT
- (2017) Zhiming Zheng et al. MEDICAL SCIENCE MONITOR
- Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
- (2017) Sha Liu et al. Cancer Medicine
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
- (2017) Yuan Miao et al. Scientific Reports
- Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
- (2016) Bahman Yousefi et al. Anti-Cancer Agents in Medicinal Chemistry
- miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis
- (2016) Weiguo Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells
- (2016) Xinfeng Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway
- (2016) Fu Gui et al. CELL BIOLOGY INTERNATIONAL
- DNA damage response regulation by microRNAs as a therapeutic target in cancer
- (2016) Maryam Majidinia et al. DNA REPAIR
- MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway
- (2016) Rong Lian et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway
- (2016) FANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer
- (2016) Huan Xia et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
- (2016) Li-Ping Zeng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Regulatory mechanisms of microRNA expression
- (2016) Lyudmila F. Gulyaeva et al. Journal of Translational Medicine
- miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways
- (2016) Xianbao Huang et al. ONCOLOGY REPORTS
- The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
- (2016) Ismael Riquelme et al. PATHOLOGY & ONCOLOGY RESEARCH
- MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway
- (2016) Lili Song et al. TUMOR BIOLOGY
- Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells
- (2016) Xue-Bin Zhang et al. TUMOR BIOLOGY
- miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer
- (2016) XUEXIANG LIU et al. Oncology Letters
- miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR–p-PI3K/AKT-c-JUN
- (2016) Mengyang Zhao et al. Nature Communications
- miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
- (2016) Xiaoyan Sun et al. Oncotarget
- MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
- (2016) Pan Chen et al. Oncotarget
- MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity
- (2016) Yang Wang et al. Oncotarget
- MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway
- (2016) Qing-yong Chen et al. Oncotarget
- Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
- (2016) Ilaria Guerriero et al. Oncotarget
- Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
- (2016) Bing Guan et al. Oncotarget
- miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
- (2016) Sherien M. El-Daly et al. Scientific Reports
- MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
- (2016) Xueju Wei et al. Cancer Medicine
- MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
- (2016) Fei Meng et al. Frontiers in Genetics
- miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer
- (2016) Merve Mutlu et al. Scientific Reports
- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
- (2015) Delinaer Wuerkenbieke et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer
- (2015) Jing Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1
- (2015) Pei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling
- (2015) Hongyu Chi BIOMEDICINE & PHARMACOTHERAPY
- The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
- (2015) Xue-jun Shao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-618 modulates cell growth via targeting PI3K/Akt pathway in human thyroid carcinomas
- (2015) L Yi et al. INDIAN JOURNAL OF CANCER
- miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway
- (2015) XIANGLIANG ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
- (2015) KANGSHENG TU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma
- (2015) Yuqin Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
- (2015) Lin Zheng et al. Journal of Translational Medicine
- Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway
- (2015) Wei-Zhang Wang et al. LEUKEMIA RESEARCH
- An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose- and Amino Acid-Deprivation
- (2015) Peiying Ye et al. MOLECULAR CELL
- miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours
- (2015) Michaela Angelika Ihle et al. Molecular Oncology
- Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway
- (2015) HAI JIN et al. ONCOLOGY REPORTS
- miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer
- (2015) DONGLI ZHAO et al. ONCOLOGY REPORTS
- miRNA-542-3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation
- (2015) TAO MA et al. ONCOLOGY REPORTS
- MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway
- (2015) Juan Du et al. TUMOR BIOLOGY
- MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer
- (2015) Zhen-Hua Wu et al. TUMOR BIOLOGY
- MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway
- (2015) Liang Shen et al. TUMOR BIOLOGY
- miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway
- (2015) HAO TANG et al. Oncology Letters
- miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway
- (2015) Ismael Riquelme et al. CELLULAR ONCOLOGY
- MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway
- (2015) Yun-Li Chang et al. Oncotarget
- MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
- (2015) Changjun He et al. Oncotarget
- miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways
- (2015) Qingmei He et al. Oncotarget
- miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway
- (2015) Lili Jiang et al. Oncotarget
- MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma
- (2015) Heounjeong Go et al. Oncotarget
- MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A
- (2015) Katsuya Ohta et al. Oncotarget
- MicroRNA-618 modulates cell growth via targeting PI3K/Akt pathway in human thyroid carcinomas
- (2015) L Yi et al. INDIAN JOURNAL OF CANCER
- Oncogenic MicroRNAs: Key Players in Malignant Transformation
- (2015) Tania Frixa et al. Cancers
- CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells
- (2015) Guan-Ting Liu et al. Oncotarget
- MicroRNA-122 Promotes Proliferation, Invasion and Migration of Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway
- (2014) Ji-Hu Lian et al. Asian Pacific Journal of Cancer Prevention
- MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma
- (2014) Gang Shen et al. CARCINOGENESIS
- MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway
- (2014) J. Li et al. CELL PROLIFERATION
- miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway
- (2014) Yan Cheng et al. FEBS LETTERS
- Mo1659 The PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Potential Relationship With Mir-125b, Mir-451 and Mir-101
- (2014) Ismael Riquelme et al. GASTROENTEROLOGY
- MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer
- (2014) Yi Yang et al. INTERNATIONAL JOURNAL OF CANCER
- miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways
- (2014) ZHENLIN LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway
- (2014) Lijun Xu et al. Journal of Translational Medicine
- Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation
- (2014) F Palacios et al. LEUKEMIA
- Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway
- (2014) Yanru Fan et al. MEDICAL ONCOLOGY
- MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma
- (2014) Qiang Xie et al. NEUROPATHOLOGY
- MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog
- (2014) Jin-Kyung Seok et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer
- (2014) WEI WANG et al. ONCOLOGY REPORTS
- Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway
- (2014) Min Sha et al. PHARMACOLOGY
- Silencing miR-21 Sensitizes Non-Small Cell Lung Cancer A549 Cells to Ionizing Radiation through Inhibition of PI3K/Akt
- (2014) Yongfu Ma et al. Biomed Research International
- Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways
- (2014) Sachin S. Rathod et al. FEBS Open Bio
- Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products)
- (2013) Shile Huang Anti-Cancer Agents in Medicinal Chemistry
- MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway
- (2013) Yanfei Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Defining the Membrane-Associated State of the PTEN Tumor Suppressor Protein
- (2013) Craig N. Lumb et al. BIOPHYSICAL JOURNAL
- PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression
- (2013) Pradeep S. Tanwar et al. CARCINOGENESIS
- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
- (2013) X. Luo et al. CELL PROLIFERATION
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
- (2013) Hana Totary-Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
- (2013) Rachana Patel et al. JOURNAL OF CLINICAL INVESTIGATION
- VEGFA and tumour angiogenesis
- (2013) L. Claesson-Welsh et al. JOURNAL OF INTERNAL MEDICINE
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
- (2013) Guangyi Zhao et al. PLoS One
- MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma
- (2013) Zong-Tao Chai et al. PLoS One
- Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
- (2013) Burhan Hassan et al. Surgical Oncology Clinics of North America
- miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway
- (2013) Weiguo Cao et al. TUMOR BIOLOGY
- microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
- (2013) ZHONGXIAN WANG et al. Oncology Letters
- The Paradox of Akt-mTOR Interactions
- (2013) Lakshmipathi Vadlakonda et al. Frontiers in Oncology
- Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma
- (2012) Xin Huang et al. AMERICAN JOURNAL OF PATHOLOGY
- Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways
- (2012) Shunsuke Noguchi et al. CANCER LETTERS
- PI3K Pathway Inhibitors: Better Not Left Alone
- (2012) Ben Markman et al. CURRENT PHARMACEUTICAL DESIGN
- Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer
- (2012) Qiao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
- (2012) Enza Piccolo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- miRNAs and regulation of cell signaling
- (2011) Atsuhiko Ichimura et al. FEBS Journal
- The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
- (2011) Yi-fang Ping et al. JOURNAL OF PATHOLOGY
- The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
- (2011) E Rao et al. LEUKEMIA
- MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
- (2010) Fazli Wahid et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers
- (2008) Chunguang Guo et al. GENES CHROMOSOMES & CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started